|
SCO1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.104010E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.598960E-01 |
| Normal-vs-Stage2 |
7.773800E-01 |
| Normal-vs-Stage3 |
7.857400E-01 |
| Normal-vs-Stage4 |
1.462580E-01 |
| Stage1-vs-Stage2 |
7.678200E-01 |
| Stage1-vs-Stage3 |
6.912000E-01 |
| Stage1-vs-Stage4 |
1.261000E-01 |
| Stage2-vs-Stage3 |
9.667800E-01 |
| Stage2-vs-Stage4 |
2.392000E-01 |
| Stage3-vs-Stage4 |
2.333200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.176100E-02 |
| Normal-vs-AfricanAmerican |
7.290200E-01 |
| Normal-vs-Asian |
7.631600E-01 |
| Caucasian-vs-AfricanAmerican |
1.290450E-01 |
| Caucasian-vs-Asian |
9.912200E-01 |
| AfricanAmerican-vs-Asian |
5.901200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.602000E-01 |
| Normal-vs-Female |
3.244200E-01 |
| Male-vs-Female |
9.157000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.205600E-01 |
| Normal-vs-Extreme_Weight |
7.067800E-01 |
| Normal-vs-Obese |
8.212800E-01 |
| Normal-vs-Extreme_Obese |
2.472400E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.866400E-01 |
| Normal_Weight-vs-Obese |
6.460600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.217000E-01 |
| Extreme_Weight-vs-Obese |
9.091000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.886000E-01 |
| Obese-vs-Extreme_Obese |
2.739000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.264400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.861400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.295180E-01 |
| Normal-vs-Age(81-100Yrs) |
1.571800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.855000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.519200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.560600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.965600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.398630E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.829600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.503600E-02 |
| Normal-VS-Type2 PRCC |
3.791200E-01 |
| Normal-VS-KIRP CIMP |
6.820400E-01 |
| Normal-VS-Unclassified PRCC |
4.787400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.326000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.403200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.729600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.429800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.468000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.286600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.494800E-01 |
| Normal-vs-N1 |
6.527400E-01 |
| Normal-vs-N2 |
4.930100E-02 |
| N0-vs-N1 |
7.877600E-01 |
| N0-vs-N2 |
1.099600E-01 |
| N1-vs-N2 |
2.839700E-02 |
|
|
